Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Identification of a specific ultrasonographic finding for differentiating hepatic angiomyolipoma from hepatocellular carcinoma.

Naito K, Shigematsu Y, Fujiwara Y, Inamura K, Togashi Y, Inoue Y, Takazawa Y, Kanda H, Matsueda K.

Clin Imaging. 2019 Nov 27;59(2):104-108. doi: 10.1016/j.clinimag.2019.10.020. [Epub ahead of print]

PMID:
31812881
2.

Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.

Fujiwara R, Inamura K, Yuasa T, Numao N, Yamamoto S, Masuda H, Kawauchi A, Takeuchi K, Yonese J.

Int J Clin Oncol. 2019 Sep 14. doi: 10.1007/s10147-019-01542-7. [Epub ahead of print]

PMID:
31522314
3.

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma.

Inamura K, Amori G, Yuasa T, Yamamoto S, Yonese J, Ishikawa Y.

Cancer Manag Res. 2019 Jul 25;11:7021-7030. doi: 10.2147/CMAR.S209205. eCollection 2019.

4.

Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.

Koh H, Hamada T, Song M, Liu L, Cao Y, Nowak JA, da Silva A, Twombly T, Morikawa T, Kim SA, Masugi Y, Kosumi K, Shi Y, Gu M, Li W, Du C, Chen Y, Li W, Liu H, Li C, Wu K, Nosho K, Inamura K, Hanyuda A, Zhang X, Giannakis M, Chan AT, Fuchs CS, Nishihara R, Meyerhardt JA, Ogino S.

JNCI Cancer Spectr. 2018 Oct;2(4):pky058. doi: 10.1093/jncics/pky058. Epub 2019 Jan 9.

5.

Preparation of metal phthalocyanine (MPc)-polymer complexes: the possible anti-cancer properties of FePc-polymer complexes.

Inamura I, Inamura K, Jinbo Y, Mihara T, Sasaoka Y.

Heliyon. 2019 Mar 29;5(3):e01383. doi: 10.1016/j.heliyon.2019.e01383. eCollection 2019 Mar.

6.

Cerebral Thromboembolism after Lobectomy for Lung Cancer: Pathological Diagnosis and Mechanism of Thrombus Formation.

Hashimoto H, Usui G, Tsugeno Y, Sugita K, Amori G, Morikawa T, Inamura K.

Cancers (Basel). 2019 Apr 5;11(4). pii: E488. doi: 10.3390/cancers11040488. Review.

7.

A case report on 111In chloride bone marrow scintigraphy in management of adrenal myelolipoma.

Yamamoto T, Koizumi M, Kohno A, Numao N, Inamura K.

Medicine (Baltimore). 2019 Feb;98(8):e14625. doi: 10.1097/MD.0000000000014625.

8.

Mesenchymal tumors of the lung: diagnostic pathology, molecular pathogenesis, and identified biomarkers.

Hashimoto H, Tsugeno Y, Sugita K, Inamura K.

J Thorac Dis. 2019 Jan;11(Suppl 1):S9-S24. doi: 10.21037/jtd.2018.12.04. Review.

9.

Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA.

Haga Y, Uemura M, Baba S, Inamura K, Takeuchi K, Nonomura N, Ueda K.

Anal Chem. 2019 Feb 5;91(3):2247-2254. doi: 10.1021/acs.analchem.8b04829. Epub 2019 Jan 23.

PMID:
30669833
10.

Gut microbiome: a key player in cancer immunotherapy.

Shigematsu Y, Inamura K.

Hepatobiliary Surg Nutr. 2018 Dec;7(6):479-480. doi: 10.21037/hbsn.2018.10.02. No abstract available.

11.

SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance.

Wasserman I, Lee LH, Ogino S, Marco MR, Wu C, Chen X, Datta J, Sadot E, Szeglin B, Guillem JG, Paty PB, Weiser MR, Nash GM, Saltz L, Barlas A, Manova-Todorova K, Uppada SPB, Elghouayel AE, Ntiamoah P, Glickman JN, Hamada T, Kosumi K, Inamura K, Chan AT, Nishihara R, Cercek A, Ganesh K, Kemeny NE, Dhawan P, Yaeger R, Sawyers CL, Garcia-Aguilar J, Giannakis M, Shia J, Smith JJ.

Clin Cancer Res. 2019 Mar 15;25(6):1948-1956. doi: 10.1158/1078-0432.CCR-18-1726. Epub 2018 Dec 26.

PMID:
30587545
12.

Unique MicroRNA and mRNA Interactions in EGFR-Mutated Lung Adenocarcinoma.

Subat S, Inamura K, Ninomiya H, Nagano H, Okumura S, Ishikawa Y.

J Clin Med. 2018 Nov 6;7(11). pii: E419. doi: 10.3390/jcm7110419.

13.

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.

Shigematsu Y, Inamura K, Yamamoto N, Mise Y, Saiura A, Ishikawa Y, Takahashi S, Kanda H.

BMC Cancer. 2018 Oct 16;18(1):980. doi: 10.1186/s12885-018-4902-8.

14.

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.

15.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Hamada T, Liu L, Nowak JA, Mima K, Cao Y, Ng K, Twombly TS, Song M, Jung S, Dou R, Masugi Y, Kosumi K, Shi Y, da Silva A, Gu M, Li W, Keum N, Wu K, Nosho K, Inamura K, Meyerhardt JA, Nevo D, Wang M, Giannakis M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

Eur J Cancer. 2018 Nov;103:98-107. doi: 10.1016/j.ejca.2018.07.130. Epub 2018 Sep 13.

16.

CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining.

Inamura K, Shigematsu Y, Ninomiya H, Nakashima Y, Kobayashi M, Saito H, Takahashi K, Futaya E, Okumura S, Ishikawa Y, Kanda H.

Cancers (Basel). 2018 Jul 31;10(8). pii: E252. doi: 10.3390/cancers10080252.

17.

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer.

Inamura K, Takazawa Y, Inoue Y, Yokouchi Y, Kobayashi M, Saiura A, Shibutani T, Ishikawa Y.

J Clin Med. 2018 Jul 10;7(7). pii: E172. doi: 10.3390/jcm7070172.

18.

TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.

Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, Morikawa T, Inamura K, Shukla SA, Wu CJ, Garraway LA, Zhang X, Wu K, Meyerhardt JA, Chan AT, Glickman JN, Rodig SJ, Freeman GJ, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Oncoimmunology. 2018 Mar 19;7(7):e1442999. doi: 10.1080/2162402X.2018.1442999. eCollection 2018.

19.
20.

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan.

Shigematsu Y, Inamura K, Mise Y, Saiura A, Rehnberg E, Yamamoto N, Ishikawa Y, Takahashi S, Kanda H.

Oncotarget. 2018 Mar 30;9(24):17056-17065. doi: 10.18632/oncotarget.24842. eCollection 2018 Mar 30.

Supplemental Content

Loading ...
Support Center